TITLE:
Epidemiological, Diagnostic and Therapeutic Aspects of Locally Advanced and/or Metastatic Breast Cancers at the Chu-Mel of Cotonou
AUTHORS:
Sèdjro Raoul Atade, Patrice Dangbemey, Roger Klipezo, Donald Adjagba, David Lionel Togbenon, Kabibou Salifou, Benjamin Hounkpatin, Justin Lewis Denakpo
KEYWORDS:
Cancer, Breast, Metastasis, Ultrasonography, Mammography
JOURNAL NAME:
Advances in Breast Cancer Research,
Vol.11 No.4,
October
27,
2022
ABSTRACT: Introduction: Breast cancer mortality remains high in most
developing countries. Benin Republic does not yet have a
technical platform required for the diagnosis and effective management of
breast cancer “according to the recommendations”. Objective: To study the epidemiological, diagnostic and
therapeutic aspects of locally advanced and/or metastatic breast cancers at the Centre Hospitalier Universitaire-de la Mère et de l’Enfant Lagune (CHU-MEL) of Cotonou from 2018 to
2021. Study Methods: This was a retrospective cross-sectional
study with a descriptive purpose, carried out from January 1, 2018 to September
30, 2021 in the Gynaecology-Obstetrics Section of the CHU-MEL of Cotonou. The study population was patients diagnosed
with locally advanced and/or metastatic breast cancers. Results: At the
end of the study, 63 cases of locally advanced and/or metastatic breast cancer
were recorded in 80 cases of breast cancer; a 74.11% prevalence of locally
advanced and metastatic breast cancer. The mean age of the patients was 42.6
years. The main reason for consultation was the discovery of a mass in the
breast (65.1%). Clinically, an orange peel
was noted in 39.6%. Mammography (47.6%) and breast ultrasonography
(42.9%) were the reference imaging workups for breast cancer diagnosis. Histopathologically, infiltrating ductal
carcinoma (94.1%) was the predominant type with Scarff-Bloom and
Richardson (SBR) grade II found in 35.3%. Progesterone and estrogen receptors
were present in 42.9%. Mastectomy with axillary node dissection was the
surgical treatment performed (80%) after neoadjuvant chemotherapy (39.6%). Only
one patient had received radiotherapy. No patient received hormone therapy. Conclusion: Locally advanced and metastatic cancers remain a
real public health problem. It is essential that major investments be
made in order to improve both their diagnosis and management.